CN112724101B - Synthetic method of 4-methylthiazole-5-formaldehyde - Google Patents

Synthetic method of 4-methylthiazole-5-formaldehyde Download PDF

Info

Publication number
CN112724101B
CN112724101B CN202110123150.1A CN202110123150A CN112724101B CN 112724101 B CN112724101 B CN 112724101B CN 202110123150 A CN202110123150 A CN 202110123150A CN 112724101 B CN112724101 B CN 112724101B
Authority
CN
China
Prior art keywords
methylthiazole
formaldehyde
reaction
catalyst
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110123150.1A
Other languages
Chinese (zh)
Other versions
CN112724101A (en
Inventor
韩津
蓝艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Yunshang New Materials Co ltd
Original Assignee
Hangzhou Kaifang Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Kaifang Technology Co ltd filed Critical Hangzhou Kaifang Technology Co ltd
Priority to CN202110123150.1A priority Critical patent/CN112724101B/en
Publication of CN112724101A publication Critical patent/CN112724101A/en
Application granted granted Critical
Publication of CN112724101B publication Critical patent/CN112724101B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention provides a synthesis method of 4-methylthiazole-5-formaldehyde, which comprises the following steps: 1) Dissolving 4-methylthiazole-5-ethanol in a solvent, and carrying out oxidation reaction under the condition of a catalyst to obtain 4-methylthiazole-5-acetic acid; 2) Heating the 4-methylthiazole-5-acetic acid obtained in the step 1) to react under the conditions of oxygen and a metal salt catalyst to obtain 4-methylthiazole-5-formaldehyde. The method takes the 4-methylthiazole-5-ethanol as a raw material, the raw material is green, cheap and easily available, the reaction process conditions are mild, the environment is friendly, the result selectivity is good, the yield is high, and the method has good economic benefits and is suitable for industrial production.

Description

Synthetic method of 4-methylthiazole-5-formaldehyde
Technical Field
The invention relates to the technical field of synthesis of medical intermediates, in particular to a synthesis method of 4-methylthiazole-5-formaldehyde.
Background
4-methylthiazole-5-formaldehyde is an important intermediate for synthesizing cefditoren pivoxil tablets serving as third-generation cephalosporin antibacterial drugs. The structural formula is
Figure BDA0002922792560000011
The compound has been studied more.
JP 45036908 proposes a method for reducing 4-methyl-5-thiazolecarboxylate and then reoxidizing it to aldehyde using lithium aluminum hydride, which is flammable, dangerous and not easy to control, and thus not suitable for industrial production.
Patent CN 1628108A reports reduction of 4-methyl-5-thiazole formate with sodium tetrahydroborate and aluminum trichloride in glyme to give 4-methyl-5-hydroxymethyl-thiazole, followed by oxidation with sodium hypochlorite or pyridinium chlorochromate to give 4-methylthiazole-5-carbaldehyde. The first step of the reaction requires low temperature and no water in the system, the conditions are harsh, the post-treatment is relatively troublesome, and the solvent recovery cost is relatively high.
In patent CN 109053623A, 2-amino-4-methylthiazole is used as a raw material, aminomethylation is carried out firstly, then vilsmeier reaction is carried out to obtain aldehyde, and finally, aminomethyl is removed by hydrogenation to obtain 4-methylthiazole-5-formaldehyde. The reaction needs a large amount of caustic soda flakes and phosphorus oxychloride in production, has high danger and corrosivity, and does not accord with the green chemical concept.
Therefore, the research and development of the synthesis process of the 4-methylthiazole-5-formaldehyde which is environment-friendly and has good economic benefit has very important significance.
Disclosure of Invention
Based on the technical problems in the background art, the invention provides a method for synthesizing 4-methylthiazole-5-formaldehyde, which takes 4-methylthiazole-5-ethanol as a raw material and generates the 4-methylthiazole-5-formaldehyde through two-step reaction. The whole reaction condition is mild, the method is environment-friendly, the result selectivity is good, the yield is high, the reaction raw materials are green, cheap and easy to obtain, and the method has good economic benefit and is suitable for industrial production.
The invention is realized by the following technical scheme:
a method for synthesizing 4-methylthiazole-5-formaldehyde comprises the following steps: 1) Dissolving 4-methylthiazole-5-ethanol in a solvent, and carrying out oxidation reaction under the condition of a catalyst to obtain 4-methylthiazole-5-acetic acid; 2) Dissolving the 4-methylthiazole-5-acetic acid obtained in the step 1) in a solvent, and heating and reacting under the conditions of oxygen and a metal salt catalyst to obtain the 4-methylthiazole-5-formaldehyde.
Wherein, in the step 1), the catalyst is piperidine nitroxide free radical or a compound containing transition metal ruthenium.
Preferably, the piperidine nitroxide radical is one or more of the following structural compounds
Figure BDA0002922792560000021
Preferably, the transition metal ruthenium-containing compound is one or a combination of more of ruthenium trichloride, ruthenium acetate, ruthenium iodide, potassium chlororuthenate, ruthenium hexacarbonyl chloride, ammonium chlororuthenate, dichloro (p-methylisoprophenyl) ruthenium dimer, tris (triphenylphosphine) ruthenium dichloride, and dichlorophenyl ruthenium dimer.
Wherein, the dosage of the catalyst in the step 1) is 1-10% of the molar weight of the 4-methylthiazole-5-ethanol when the catalyst is piperidine nitroxide radical; when the catalyst is a compound containing transition metal ruthenium, the dosage of the compound is 0.1 to 10 percent of the molar weight of the 4-methylthiazole-5-ethanol.
Wherein, the oxidant of the oxidation reaction in the step 1) is one or a combination of more of sodium hypochlorite, sodium chlorite, sodium perchlorate, sodium periodate and trichloroisocyanuric acid; the dosage of the oxidant is 100-400% of the molar weight of the 4-methylthiazole-5-ethanol.
In the step 1), the solvent is one or more of acetone, acetonitrile, propionitrile, benzonitrile, succinonitrile, dichloromethane, chloroform, 1, 2-dichloroethane, methyl cyclopentyl ether, acetic acid, ethyl acetate, tetrahydrofuran, 2-methyltetrahydrofuran, and N, N-dimethylformamide.
Wherein, the step 1) also comprises a cocatalyst and/or a basic additive; the dosage of the cocatalyst is 1-20% of the molar weight of 4-methylthiazole-5-ethanol.
Preferably, the cocatalyst is bromide; preferably, the cocatalyst is potassium bromide, sodium bromide, hydrogen bromide or sodium hypobromite.
Preferably, the basic additive is one or more of sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium monohydrogen phosphate, and potassium monohydrogen phosphate.
Preferably, in step 1), the reaction temperature is 0 to 50 ℃.
Wherein, in the step 2), the dosage of the metal salt catalyst is 1-10% of the molar weight of the 4-methylthiazole-5-acetic acid.
Wherein, in the step 2), the metal salt catalyst is copper salt or iron salt; more preferably copper chloride, copper bromide, copper acetate, copper nitrate, copper sulfate, copper trifluoromethanesulfonate, copper trifluoroacetate, iron trichloride, iron nitrate or iron sulfate.
In the step 2), the reaction solvent is one or more of tetrahydrofuran, 2-methyltetrahydrofuran, dimethyl sulfoxide and 1, 3-dimethyl-2-imidazolidinone.
Wherein in the step 2), the temperature of the heating reaction is 50-200 ℃.
The starting materials and reagents of the invention are commercially available.
The invention has the beneficial effects that:
compared with the reported method, the synthesis method has the advantages of cheap and easily obtained reaction raw materials, mild whole reaction conditions, environmental friendliness, good result selectivity, high yield, green and easily obtained reaction raw materials, good economic benefit and suitability for industrial production.
Drawings
FIG. 1 is a synthetic route of 4-methylthiazole-5-carbaldehyde proposed by the present invention
FIG. 2 gas chromatogram of 4-methylthiazole-5-carbaldehyde prepared by the present invention
Detailed Description
In order to make the technical solutions of the present invention better understood by those skilled in the art, the technical solutions of the present invention are further described in detail with reference to specific examples below.
Example 1
71.6g (0.5 mol) of 4-methylthiazole-5-ethanol, 3.12g (0.02 mol) of 2, 6-tetramethylpiperidine oxide and 200mL of acetonitrile are added into a three-neck flask, the mixture is fully stirred, the temperature is raised to 35 ℃, 113.05g (1.0 mol) of 80wt% sodium chlorite aqueous solution and 6.7g (0.01 mol) of 10wt% sodium hypochlorite aqueous solution are slowly added, the mixture is continuously stirred and reacted for 4 hours at the temperature of 35 ℃, and the reaction is detected by gas chromatography.
After the reaction is finished, quenching the reaction by using a sodium sulfite solution, adjusting the pH value of the system to 2-3 by using hydrochloric acid, concentrating under negative pressure to evaporate acetonitrile, adding 300mL of ethyl acetate, washing for 2 times by using 50mL of water, washing for one time by using a saturated sodium chloride solution, standing for layering, recovering ethyl acetate by organic phase vacuum distillation, and remaining 4-methylthiazole-5-acetic acid for later use;
putting the 4-methylthiazole-5-acetic acid obtained in the last step, 9g (0.05 mol) of copper acetate and 10mL of 2-methyltetrahydrofuran into a high-pressure reaction kettle, introducing oxygen into the reaction kettle to maintain the pressure in the kettle to be 0.5MPa, heating to 120 ℃, stirring for reacting for 10 hours, and monitoring the reaction by using gas chromatography.
After the reaction, insoluble matter was removed by filtration, 300mL of ethyl acetate was added, washing was performed with 50mL of water for 2 times, washing was performed with saturated sodium chloride solution once, the aqueous layer was extracted with 20mL of ethyl acetate twice, the organic phases were combined, dried overnight with anhydrous sodium sulfate, the solvent was recovered by distillation under reduced pressure to obtain a pale yellow solid, which was recrystallized from n-heptane to obtain pale yellow crystalline 4-methylthiazole-5-carbaldehyde with a content of 99% in a yield of 82%.
Example 2
71.6g (0.5 mol) of 4-methylthiazole-5-ethanol, 0.9g (0.005 mol) of 4-hydroxy-2, 6-tetramethylpiperidine oxide, 1.03g (0.01 mol) of sodium bromide, 200mL of acetone and 20mL of 5% sodium carbonate solution are added into a three-neck flask, the mixture is fully stirred, the temperature is reduced to 0 ℃, 116.2g (0.5 mol) of trichloroisocyanuric acid is added in a small amount for a plurality of times, the temperature is controlled not to exceed 20 ℃, and the stirring reaction is continued for 2 hours after the addition.
After the reaction is finished, quenching the reaction by using a sodium sulfite solution, adjusting the pH of the system to 2-3 by using hydrochloric acid, concentrating under negative pressure to evaporate the solvent, adding 300mL of ethyl acetate, washing with 50mL of water for 2 times, washing with a saturated sodium chloride solution for one time, standing for layering, recovering ethyl acetate by organic phase vacuum distillation, and keeping the rest of 4-methylthiazole-5-acetic acid for later use;
putting the 4-methylthiazole-5-acetic acid obtained in the last step, 0.81g (0.005 mol) of ferric trichloride solution and 10mL of dimethyl sulfoxide into a high-pressure reaction kettle, introducing oxygen into the reaction kettle to maintain the pressure in the kettle to be 0.5MPa, heating to 150 ℃, and stirring for reacting for 5 hours.
After the reaction is finished, insoluble substances are removed by filtration, 300mL of ethyl acetate is added, the mixture is stirred for 30 minutes and then is kept stand for layering, a water layer is extracted twice by 20mL of ethyl acetate, organic phases are combined and washed by 50mL of water for 2 times, the mixture is dried overnight by anhydrous sodium sulfate, the solvent is recovered by reduced pressure distillation to obtain a light yellow solid, and the light yellow solid is recrystallized by n-heptane to obtain light yellow crystal-shaped 4-methylthiazole-5-formaldehyde with the content of 99 percent and the yield of 77 percent.
Example 3
71.6g (0.5 mol) of 4-methylthiazole-5-ethanol, 50mL of acetonitrile, 50mL of ethyl acetate and 20mL of water were put in a three-necked flask, and after sufficiently stirring at room temperature, 1.04g (0.005 mol) of ruthenium trichloride was added, 213.9g (1 mol) of sodium periodate was added in portions, and after completion of the addition, the reaction was continued to stir at room temperature for 2 hours.
After the reaction is finished, quenching the reaction by using a saturated sodium sulfite solution, filtering to remove insoluble substances, adjusting the pH of the system to 2-3 by using hydrochloric acid, concentrating under negative pressure to evaporate the solvent, adding 300mL of ethyl acetate, washing with 50mL of water for 2 times, washing with a saturated sodium chloride solution once, standing for layering, performing organic phase reduced pressure distillation to recover ethyl acetate, and recovering 4-methylthiazole-5-acetic acid for later use;
putting the 4-methylthiazole-5-acetic acid obtained in the last step, 1.34g (0.01 mol) of copper chloride and 10mL of 2-methyltetrahydrofuran into a high-pressure reaction kettle, introducing oxygen into the reaction kettle to maintain the pressure in the kettle to be 0.5MPa, heating to 60 ℃, and stirring for reacting for 15 hours.
After the reaction is finished, filtering to remove insoluble substances, adding 300mL of ethyl acetate, stirring for 30 minutes, standing for layering, extracting a water layer twice with 20mL of ethyl acetate, combining organic phases, washing with 50mL of water for 2 times, drying overnight with anhydrous sodium sulfate, distilling under reduced pressure to recover the solvent to obtain a light yellow solid, and recrystallizing with n-heptane to obtain light yellow crystalline 4-methylthiazole-5-formaldehyde with the content of 99% and the yield of 87%.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.

Claims (4)

1. A method for synthesizing 4-methylthiazole-5-formaldehyde, which is characterized by comprising the following steps: 1) Dissolving 4-methylthiazole-5-ethanol in a solvent, and carrying out oxidation reaction under the condition of a catalyst to obtain 4-methylthiazole-5-acetic acid; 2) Dissolving the 4-methylthiazole-5-acetic acid obtained in the step 1) in a solvent, introducing oxygen into a reaction kettle to maintain the pressure in the kettle to be 0.5MPa, and heating and reacting under the conditions of oxygen and a metal salt catalyst to obtain 4-methylthiazole-5-formaldehyde;
in the step 1), the catalyst is ruthenium trichloride; the oxidant is one or more of sodium hypochlorite, sodium chlorite, sodium perchlorate, sodium periodate and trichloroisocyanuric acid;
in the step 2), the dosage of the metal salt catalyst is 2% of the molar weight of 4-methylthiazole-5-ethanol; the metal salt catalyst is copper chloride; the reaction solvent is 2-methyltetrahydrofuran; the temperature of the heating reaction was 60 ℃.
2. The method for synthesizing 4-methylthiazole-5-formaldehyde according to claim 1, wherein in the step 1), the amount of the catalyst ruthenium trichloride is 0.1 to 10 percent of the molar amount of the 4-methylthiazole-5-ethanol.
3. The method for synthesizing 4-methylthiazole-5-carbaldehyde according to claim 1, wherein the amount of the oxidant used in the step 1) is 100 to 400 percent of the molar amount of 4-methylthiazole-5-carbaldehyde.
4. The method for synthesizing 4-methylthiazole-5-carbaldehyde according to claim 1, wherein in the step 1), the solvent is one or more of acetone, acetonitrile, propionitrile, benzonitrile, succinonitrile, dichloromethane, chloroform, 1, 2-dichloroethane, methyl cyclopentyl ether, acetic acid, ethyl acetate, tetrahydrofuran, 2-methyltetrahydrofuran, and N, N-dimethylformamide.
CN202110123150.1A 2021-01-29 2021-01-29 Synthetic method of 4-methylthiazole-5-formaldehyde Active CN112724101B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110123150.1A CN112724101B (en) 2021-01-29 2021-01-29 Synthetic method of 4-methylthiazole-5-formaldehyde

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110123150.1A CN112724101B (en) 2021-01-29 2021-01-29 Synthetic method of 4-methylthiazole-5-formaldehyde

Publications (2)

Publication Number Publication Date
CN112724101A CN112724101A (en) 2021-04-30
CN112724101B true CN112724101B (en) 2022-12-09

Family

ID=75594648

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110123150.1A Active CN112724101B (en) 2021-01-29 2021-01-29 Synthetic method of 4-methylthiazole-5-formaldehyde

Country Status (1)

Country Link
CN (1) CN112724101B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833459B2 (en) * 2002-04-26 2004-12-21 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of thiazole intermediate

Also Published As

Publication number Publication date
CN112724101A (en) 2021-04-30

Similar Documents

Publication Publication Date Title
CN109320498B (en) Preparation method of 3-bromo-1- (3-chloro-2-pyridyl) -1H-pyrazole-5-alkyl formate
CN112250685B (en) Preparation method of indolo [2,3-A ] carbazole
CN114181191B (en) Synthesis method of cyclic sulfate
CN109369545B (en) Synthesis process of 2-methyl-5-pyrazine formate
CN113549048B (en) Preparation method of ethylene sulfite
CN112724101B (en) Synthetic method of 4-methylthiazole-5-formaldehyde
CN111170846B (en) Method for preparing 3,3-dimethyl-2-oxo-butyric acid
CN110950778A (en) Process and catalyst system for preparing aromatic malononitrile
CN114853658B (en) Synthesis method of 9- (4-bromophenyl) carbazole
WO2022097115A1 (en) An improved process for preparation of prohexadione and its calcium salt
CN101696153B (en) Preparation method of 3,3-dimethyl-1-butanol
CN104987325B (en) A kind of preparation method of voriconazole
CN113004248A (en) Method for synthesizing carbazole compound by catalyzing hydrocarbon amination reaction with cobalt
CN111574397A (en) Green synthesis method of prothioconazole intermediate
CN113185455A (en) Preparation method of 2-hydroxy-6-trifluoromethylpyridine
JP4239038B1 (en) Process for producing dialkoxythiophene and alkylenedioxythiophene
CN113336780B (en) Preparation method of 2-formyl-4- (4-cyanophenoxy) phenylboronic acid pinacol ester
CN114478315B (en) Method for catalytic reduction of irosartan biphenyl waste residues by using halogen-modified Pd/C catalyst
CN110452139B (en) Preparation method of 2-methyl-3-bromo-6-methylsulfonyl benzonitrile
JP3001626B2 (en) 2-Chloropropionaldehyde trimer and method for producing the same
CN113651684A (en) Preparation method of 4-hydroxy-2-butynoic acid
CN1112346C (en) Process for synthesizing phenylpyruvic acid by catalytic dioxonation
CN108069897B (en) Method for synthesizing nicotinic acid by using carbon dioxide
CN114195645A (en) Preparation method of o-nitrobenzaldehyde
CN114805015A (en) Synthesis process of 2, 4-dichloro-9, 9-dimethyl-9H-fluorene

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20231201

Address after: Building B, No. 2, Jihua Innovation Industrial Park, No. 4206 Xiaoqing Avenue, Hongshan Farm, Xiaoshan District, Hangzhou City, Zhejiang Province, 310000

Patentee after: Hangzhou Yunshang New Materials Co.,Ltd.

Address before: Room 02, 2-2 / F, building 8, 972 Moganshan Road, Gongshu District, Hangzhou City, Zhejiang Province 310000

Patentee before: Hangzhou Kaifang Technology Co.,Ltd.